Lumbosacral Spinal Stenosis - Non-Invasive Postural Therapy for Older Adult Veterans

NCT ID: NCT06089746

Last Updated: 2025-11-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-11-15

Study Completion Date

2026-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Lumbosacral spinal stenosis (LSS) is a leading cause of limited mobility, reduced independence, and poor health outcomes in older adults, and is very common in older adult Veterans. Several years ago, major research studies indicated that surgery for LSS was more effective than usual (medical) management. Nonetheless, there are many patients for whom surgery is not the ideal therapy. There have been reports that modifications in daily activities including temporary use of a modified rolling walker and changes in sleep positioning may help relieve LSS. The investigators have assembled a VA team to study this carefully. The investigators will recruit a small group of older adult Veterans with LSS to try out this program; the investigators will monitor them closely for relief of their symptoms and improvements in walking. The investigators will, as part of this small study, try to understand potential barriers to use of this therapy. The investigators will interview the Veterans and healthcare providers to identify problems that may arise in trying this therapy. If this small study works, the investigators plan to expand the effort.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lumbar Spinal Stenosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Feasibility

Patients with LSS will receive DME and training to support continuous maintenance of flexion posture during the 6 week trial. All participants will be asked to wear actigraphs and pedometers intermittently and to complete questionnaires and mobility assessments.

Group Type EXPERIMENTAL

NIPT

Intervention Type OTHER

Coordinated suite of DME and training to support continuous maintenance of flexion posture during the 6 week trial.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

NIPT

Coordinated suite of DME and training to support continuous maintenance of flexion posture during the 6 week trial.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Veterans receiving care at participating VA
* Ability to read and write English and understand instructions
* Agrees to comply with instructions
* Symptoms for over 3 months
* Diagnosis of Lumbar Spinal Stenosis as the cause of symptoms
* Discomfort involving low back pain and / or neurogenic claudication of legs or thighs
* Back and/or leg symptoms greater than 3/10 provoked by walking and / or standing
* X ray, CT, or MRI performed within the last 12 months shows Lumbar Spinal Stenosis at 1 or 2 levels
* Prior treatment for Spinal Stenosis including therapy, medication, epidural injections, but not surgery
* Relief of pain (standardly within 5 minutes) by sitting down
* Ability to walk 50 feet without a cane or walker
* General health presents ability to increase activity level if Back and / or leg symptoms resolve
* If home has stairs and patient uses multiple levels, must have steady handrail
* Transportation routinely available by car or car service and not by bus
* Home location allows restriction of walking to flat surfaces (lack of hills), with availability to increase ambulation on flat surfaces

Exclusion Criteria

* Previous Low Back Surgery for SS including decompression or fusion
* Successful Spinal Stenosis Treatment (such as injection) over the prior 3 months
* X ray, CT, or MRI shows Lumbar Spinal Stenosis in 3 or 4 levels
* Prior Lumbar Fracture
* Scoliosis with Cobb angle over 20 degrees on weight bearing AP Views
* Inflammatory arthropathy involving the Lumbar Spine, such as RA
* Radiculopathy attributed to herniated disc
* Suspected or confirmed moderate to severe large fiber neuropathy
* Failure of relief of back or leg pain brought on by standing or walking, within 5 minutes, by sitting down
* Rapid increase in symptoms with lumbar flexion such as sitting, Increase in symptoms brought on by leaning on grocery cart or walker
* Reduced symptoms by lumbo-sacral extension
* Vascular Claudication with ABI less than 60 or over 140
* Prior bypass or stent surgery for PAD
* Current foot, ankle, leg, or thigh infection or open ulcer
* Current use of a Brace for foot, ankle, or knee pathology,
* Moderate to severe arthritis of the Hip, knee, ankle or foot preventing pain free ambulation greater than 1 block
* Neurologic or neurodegenerative induced gait pathology such as CVA, Parkinson's, NPH, Cervical Myelopathy
* Current Medico Legal issues, active substance use, SI, HI, or other factors that may interfere with completion of six-week treatment trial
* Planned surgery or procedure in the 6-week study period
Minimum Eligible Age

60 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

VA Office of Research and Development

FED

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Beth B. Hogans, MD

Role: PRINCIPAL_INVESTIGATOR

Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD

Baltimore, Maryland, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Beth B Hogans, MD

Role: CONTACT

Phone: (410) 605-7000

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Beth B Hogans, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

E4412-P

Identifier Type: -

Identifier Source: org_study_id